A platform to prevent relapse and better monitoring of mental disorders. We help healthcare professionals to improve clinical outcomes while empowering patients with individualising digital treatment.
We provide a bone cement designed for osteoporotic bone. It gives the patient better treatment, less risk for new fractures and better quality of life after a fragility fracture. We aim to collaborate with bone cement manufacturers for fast time to market.
Science generates data but knowledge grows slowly. We store, integrate and connect biomedical data to make drug development and therapies truly individual.
We are creating a robot that can wash and disinfect or sterilise hospital floors regardless of what hour of day or night or number of cleanings needed. Our product will be easy to use and maintain, drastically reduce infections rate, treatment and personnel costs. More than that, patients feel safe and are reassured that their safety is your top priority.
Our product is a degradable stent that will revolutionise the market. Providing lower treatment cost, avoiding second surgery for stent removal, while reducing the risk of infection and eliminates the cases of “forgotten” stents. It’s for patients who need temporary urological stents, who need to have a second surgery for stent removal.
The wearable that fight stress by analyzing breathing patterns in realtime. iBreve is founded by 2 former Google employees aiming to create a world free of stress related diseases. iBreve’s digital health solution helps people to cope with stress by analyzing breathing patterns in realtime.
Smart electronic flowmeter that improves oxygen therapy by realtime adaptation of oxygen flow through analysis of oxygen data (saturation, breaths per minute), communicates with other devices to have an beneficial effect on the rehabilitation process of the patient and delivers oxygen much more comfortably whilst reducing oxygen consumption and spillage.
People with Essential Tremor have involuntary vibrations in the arms, making them unable to perform even the simplest tasks in life, such as eating and drinking. Current treatments have severe side-effects, causing patients to reject it and live with the consequences. STIL technology is capable of mechanically suppressing tremor and will provide a stable future for 30 million people worldwide.
Clemedi fights antibiotic resistance by giving doctors all the information needed for the right treatment early on, therefore reducing hospital costs and improving patient care.
The fifth edition of the EIT Health Validation Lab came to an end for 10 startups at YES!Delft this week. The Pitch Day marked the close of the two-month program and brought a number of highlights with it. The event, which welcomed more than 100 guests, gave a platform to all participating startups to pitch […]Read more
Yes!Delft startup Momo Medical had an amazing announcement at yesterday’s Venture Café Rotterdam. FundIQare wants to support Momo Medical with a financial injection to expand the production capacity and scaling up the startup. They will also get the opportunity to further develop their technology in a living lab environment. Momo Medical, founded in 2017, […]Read more
Delft, November 2, 2018 – LaunchDay marked the end of the two-month EIT Health Validation Lab program for 10 startups at YES!Delft on Thursday. Over the course of eight weeks, the teams traveled through the Netherlands and across Europe to validate the business potential of their ideas with leading universities, healthcare companies and hospitals. For […]Read more